At Neuphoria Therapeutics, we are dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, we aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future.
To learn more about the company, pipeline and collaboration opportunities, visit us at www.neuphoriatx.com
Company Details
- Employees
- 36
- Address
- 100 Summit Dr, Burlington,massachusetts 01803,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neuphoriatx.com
- Keywords
- biopharmaceutical, central nervous system disorders, anxiety, PTSD, social anxiety, neuropsychiatry.
- HQ
- Burlington, Massachusetts
Neuphoria Therapeutics Inc Questions
Neuphoria Therapeutics Inc's website is http://www.neuphoriatx.com
Neuphoria Therapeutics Inc's LinkedIn profile is https://www.linkedin.com/company/neuphoriatx
Neuphoria Therapeutics Inc has
36 employees.
View email and phone details for 36
employees at Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc's industry is
Biotechnology Research
Neuphoria Therapeutics Inc's top competitors are
Kariya Pharmaceuticals,
Lipocine Inc.,
Alpha Cognition, Inc.,
Abcuro, Inc,
Relmada Therapeutics, Inc,
Neuphoria Tms,
Actinogen Medical,
Phragma Therapeutics,
Encephalos Life Sciences Llc,
Lb Pharmaceuticals Inc.
Neuphoria Therapeutics Inc's categories are Biotechnology Research
